Glenmark Life Sciences Q4 Results

  • BSE: 543322
  • NSE: GLS
  • ISIN: INE03Q201024
  • Sector: Biotechnology & Drugs
BSE
821.851.45 (0.18%)
Volume1.63 K
Updated: Wed 22 May, 2024 | 10:27:11
NSE
820.05-0.10 (-0.01%)
Volume33.91 K
Updated: Wed 22 May, 2024 | 10:13:52
Today: 807.80
821.85
52-Wk: 512.70
904.20

Q4 Results Highlights

  • Total Income
    ₹536.60 Cr.
    (-78.20%)
  • Operating Profit
    ₹126.91 Cr.
    (-79.24%)
  • Profit After Tax
    ₹97.94 Cr.
    (-74.87%)
  • Operating Margin
    23.65%
    (-4.81%)
Note: Comparison is on YoY basis

Quarterly - Glenmark Life Sciences Q4 Results

*All figures in crores except per share values
Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
Total Revenue 536.602,191.88-74.86%2,461.12-78.20%
Selling/ General/ Admin Expenses Total 72.26151.23-57.10%158.43-54.39%
Depreciation/ Amortization 14.5361.21-76.19%59.03-75.38%
Other Operating Expenses Total 84.2047.9838.15%37.99121.64%
Total Operating Expense 409.691,658.27-75.72%1,849.65-77.85%
Operating Income 126.91533.61-71.58%611.47-79.24%
Net Income Before Taxes 129.68433.83-59.00%521.24-75.12%
Net Income 97.94323.65-59.65%389.68-74.87%
Diluted Normalized EPS 7.9733.47-68.25%40.30-80.22%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumFor youGet App